adenosine diphosphate has been researched along with pd 123319 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madsen, KM; Tisher, CC; Tojo, A | 1 |
| Casado, S; Farré, J; Gómez, J; Jiménez, A; López-Blaya, A; López-Farré, A; Montón, M; Núñez, A; Sánchez de Miguel, L; Zalba, LR | 1 |
2 other study(ies) available for adenosine diphosphate and pd 123319
| Article | Year |
|---|---|
Angiotensin II regulates H(+)-ATPase activity in rat cortical collecting duct.
Topics: Adenosine Diphosphate; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Biphenyl Compounds; Collagenases; Ethylmaleimide; Female; H(+)-K(+)-Exchanging ATPase; Imidazoles; Kidney Cortex; Kidney Tubules, Collecting; Losartan; Macrolides; Proton-Translocating ATPases; Pyridines; Rats; Rats, Sprague-Dawley; Tetrazoles | 1994 |
Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antibodies, Monoclonal; Benzimidazoles; Benzoates; Binding, Competitive; Biphenyl Compounds; Blood Platelets; Dose-Response Relationship, Drug; Humans; Imidazoles; Irbesartan; Losartan; Platelet Activation; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Telmisartan; Tetrazoles; Thromboxane A2; Time Factors; Valine; Valsartan | 2000 |